Cause-and-Effect relationship between FGFR1 expression and epithelial-mesenchymal transition in EGFR-mutated non-small cell lung cancer cells
- 1 June 2019
- journal article
- research article
- Published by Elsevier in Lung Cancer
- Vol. 132, 132-140
Abstract
No abstract availableKeywords
Funding Information
- Dagmar Marshalls Mindelegat
- Fabrikant Einar Willumsens Mindelegat
- Marie og Børge Kroghs Fond
- P. A. Messerschmidt og Hustrus Fond
- Thora og Viggo Grove´s Mindelegat
- Familien Erichsens Familiefond
This publication has 54 references indexed in Scilit:
- A mechanism of resistance to gefitinib mediated by cellular reprogramming and the acquisition of an FGF2-FGFR1 autocrine growth loopOncogenesis, 2013
- Meta-Analysis of Gene Expression Signatures Defining the Epithelial to Mesenchymal Transition during Cancer ProgressionPLOS ONE, 2012
- An EMT–Driven Alternative Splicing Program Occurs in Human Breast Cancer and Modulates Cellular PhenotypePLOS Genetics, 2011
- Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR InhibitorsScience Translational Medicine, 2011
- ZEB1-responsive genes in non-small cell lung cancerCancer Letters, 2011
- Knockdown of ZEB1, a master epithelial-to-mesenchymal transition (EMT) gene, suppresses anchorage-independent cell growth of lung cancer cellsCancer Letters, 2010
- Fibroblast growth factor receptor-mediated signals contribute to the malignant phenotype of non-small cell lung cancer cells: therapeutic implications and synergism with epidermal growth factor receptor inhibitionMolecular Cancer Therapeutics, 2008
- Alternative inclusion of fibroblast growth factor receptor 2 exon IIIc in Dunning prostate tumors reveals unexpected epithelial mesenchymal plasticityProceedings of the National Academy of Sciences, 2006
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004